GSK’s and Regeneron’s COVID-19 treatments don’t work against omicron and its subvariants, a World Health Organization panel said Sept. 16.
Read the full post on Becker's Hospital Review - Healthcare News
WHO discourages use of GSK, Regeneron antibody drugs against omicron
